Answers are grounded in this paper and cite their sources.
Patients with locally advanced cervical cancer have a 20–30% risk of residual disease after completion of standard-of-care chemoradiation. A reliable and patient-specific method to predict treatment response is currently lacking but would be valuable for selecting therapeutic regimens with improved outcomes. We developed an MRI-based mathematical model for tumor cell movement, proliferation, and response to chemoradiation. The model was calibrated for each patient using their own MRI data before (V1) and after two weeks (V2) of chemoradiation. In the study cohort of 10 patients, the concordance correlation coefficients between the observed and predicted changes in tumor cellularity and volume from V1 to V3 (after five weeks of chemoradiation) were 0.96 and 0.78, respectively. Thus, our model can accurately predict response to chemoradiation for cervical cancer patients using each patient’s MRI data, thereby offering potential for personalizing chemoradiation regimens during treatment.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: